Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Societe des Produits Nestle S.A. Create: Alert

All | News | Filings
Date FiledTypeDescription
02/02/2023 SC 13G/A Societe des Produits Nestle S.A. reports a 15.1% stake in Axcella Health Inc.
10/19/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/17/2022 4 Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Axcella Health Inc.
Txns: Bought 3,658,536 shares @ $1.64, valued at $6M
03/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/12/2021 3 NESTLE SA (10% Owner) has filed a Form 3 on Prometheus Biosciences, Inc.
02/12/2021 SC 13G/A Societe des Produits Nestle S.A. reports a 11.5% stake in Axcella Health Inc.
10/15/2020 4 Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Bought 43,435,583 shares @ $34.5, valued at $1498.5M
Bought 10,681,704 shares @ $34.5, valued at $368.5M
10/13/2020 SC 13D/A Societe des Produits Nestle S.A. reports a 100% stake in Aimmune Therapeutics, Inc.
10/13/2020 SC 13E3/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/05/2020 SC 13E3/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/05/2020 SC 13E3/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
09/29/2020 SC 13E3/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
09/21/2020 SC 13E3/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
09/14/2020 SC 13E3 Form SC TO-T - Tender offer statement by Third Party:
09/14/2020 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
09/09/2020 4 Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Axcella Health Inc.
Txns: Acquired 4,305,541 shares @ $4.42, valued at $19M
08/31/2020 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
08/31/2020 SC 13D/A Societe des Produits Nestle S.A. reports a 19.6% stake in Aimmune Therapeutics, Inc.
05/21/2020 4 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 4 on Axcella Health Inc.
Txns: Bought 1,936,842 shares @ $4.75, valued at $9.2M
04/24/2020 4 Societe des Produits Nestle S.A. (10% Owner) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Bought 1,000,000 shares @ $31.97, valued at $32M
Bought 525,634 preferred shares @ $319.675, valued at $168M
Acquired 12,727,113 shares @ $16.11, valued at $205M
Acquired 525,634 preferred shares @ $161.1, valued at $84.7M
04/24/2020 3 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 3 on Aimmune Therapeutics, Inc.
02/14/2020 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy